Applied Therapeutics (APLT) announced the FDA has issued a Complete Response Letter for the New Drug Application for govorestat, for ...
The FDA has issued a Complete Response Letter regarding the NDA for govorestat for the treatment of classic galactosemia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback